Exosomal microRNAs as diagnostic biomarkers and therapeutic applications in neurodegenerative diseases

Xuehereti Sataer,Zhu Qifeng,Zhang Yingying,He Chunhua,Feng Bingzhenga,Xu Zhiran,Li Wanli,Yang Yuwei,Chen Shuangfeng,Wu Lingling,Huang Hongri,Chen Jibing,Ren Xiaoping,Gao Hongjun
DOI: https://doi.org/10.1080/01616412.2022.2129768
Abstract:Originating from slow irreversible and progressive loss and dysfunction of neurons and synapses in the nervous system, neurodegenerative diseases (NDDs) affect millions of people worldwide. Common NDDs include Parkinson's disease, Alzheimer's disease multiple sclerosis, Huntington's disease, and amyotrophic lateral sclerosis. Currently, no sensitive biomarkers are available to monitor the progression and treatment response of NDDs or to predict their prognosis. Exosomes (EXOs) are small bilipid layer-enclosed extracellular vesicles containing numerous biomolecules, including proteins, nucleic acids, and lipids. Recent evidence indicates that EXOs are pathogenic participants in the spread of neurodegenerative diseases, contributing to disease progression and spread. EXOs are also important tools for diagnosis and treatment. Recently, studies have proposed exosomal microRNAs (miRNAs) as the targets for therapies or biomarkers of NDDs. In this review, we outline the latest research on the roles of exosomal miRNAs in NDDs and their applications as potential diagnostic and therapeutic biomarkers, targets, and drugs for NDDs.
What problem does this paper attempt to address?